PortView
Revelation Biosciences (REVBW) Stock Analysis
NASDAQHealthcareBiotechnology
What Revelation Biosciences does
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering immunology-based therapies and diagnostic tools aimed at preventing and treating a range of illnesses. Their flagship therapeutic, REVTx-99, is an intranasal immunomodulator designed to both prevent and treat a broad spectrum of respiratory viral infections, including SARS-CoV-2 (and its variants), influenza A and B, parainfluenza, rhinovirus, and RSV. Furthermore, its potential extends to addressing allergic rhinitis and chronic nasal congestion. The company's pipeline also includes REVTx-200, an intranasal immunomodulator intended as an adjunct to enhance the efficacy of intramuscular vaccinations, thereby boosting immunity. Additionally, they are developing REVDx-501, a rapid diagnostic test designed for convenient home use to detect respiratory viral infections. Established in 2019, the company is headquartered in New York, New York.
Key metrics
ETFs linked to REVBW
Broad-market and Healthcare sector ETFs an investor holding Revelation Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how REVBW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze REVBW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Revelation Biosciences?
- Revelation Biosciences trades under the ticker REVBW on NASDAQ.
- Which exchange is REVBW listed on?
- REVBW is listed on NASDAQ.
- What sector does Revelation Biosciences operate in?
- Revelation Biosciences is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze REVBW in a portfolio?
- PortView shows REVBW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.